Gilead Wants $15.5M In Fees From Merck After Hep C Upset
Gilead Sciences Inc. told a California federal court Tuesday that Merck & Co. Inc. should have to hand over $15.5 million in attorneys' fees following a judge's decision that the latter...To view the full article, register now.
Already a subscriber? Click here to view full article